|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1996-1-18
|
|
pubmed:abstractText |
To determine the relative efficacy of amantadine, pemoline, and placebo in treatment of multiple sclerosis (MS)-related fatigue.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1956-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7501140-Adolescent,
pubmed-meshheading:7501140-Adult,
pubmed-meshheading:7501140-Amantadine,
pubmed-meshheading:7501140-Analysis of Variance,
pubmed-meshheading:7501140-Central Nervous System Stimulants,
pubmed-meshheading:7501140-Double-Blind Method,
pubmed-meshheading:7501140-Fatigue,
pubmed-meshheading:7501140-Female,
pubmed-meshheading:7501140-Humans,
pubmed-meshheading:7501140-Male,
pubmed-meshheading:7501140-Middle Aged,
pubmed-meshheading:7501140-Multiple Sclerosis,
pubmed-meshheading:7501140-Pemoline
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
|
|
pubmed:affiliation |
Multiple Sclerosis Comprehensive Care Center, State University of New York (SUNY) at Stony Brook, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
